REG - Xaar PLC - Grant of options under SAYE Scheme

XaarAnnouncement

03/11/2020 11:30

RNS Number : 1121E
  
Xaar PLC
  
03 November 2020
  
 

Xaar plc (the "Company")
Grant of Options - Sharesave (SAYE)
The Company announces that on 2 November 2020 the following persons discharging managerial responsibilities of the Company were granted share options over ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") under the terms of the 2017 Sharesave Scheme (the "Scheme"), at an exercise price per Ordinary Share of £1.02:



Name


Role


No. of options* granted over Ordinary Shares


Total no. of options** held following grant




John Mills


Chief Executive Officer


5,294


550,622




Ian Tichias


Chief Finance Officer


5,294


225,294



 
* Options granted on 2 November 2020 under the Scheme
** Options granted over Ordinary Shares under all schemes
No consideration was paid for the grant of these options.
The options granted under the Scheme are, in normal circumstances, not exercisable until the completion of a 3 year savings period, which will end on 1 December 2023 and will then be exercisable for a period of 6 months. The exercise period will therefore be in normal circumstances, from 1 December 2023 until 31 May 2024.
This notification is made in accordance with DTR 3.1.4 R(1).
Enquiries:



Xaar plc


 




Ian Tichias
Chief Finance Officer
& Company Secretary
 


01223 423 663



 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHKKNBBDBDDFDK